Cargando…

Correlation Between Baseline 18F-FDG PET/CT Findings and CD38- and CD138-Expressing Myeloma Cells in Bone Marrow and Clinical Parameters in Patients with Multiple Myeloma

OBJECTIVE: The aim of this study was to evaluate the relation between the rate of fluorine-18 (18F) fludeoxyglucose (FDG) uptake and CD38 and CD138 expression in myeloma cells in bone marrow and other clinical parameters in patients with multiple myeloma (MM). MATERIALS AND METHODS: Patients with th...

Descripción completa

Detalles Bibliográficos
Autores principales: Cengiz, Arzu, Arda, Hayri Üstün, Döğer, Firuzan, Yavaşoğlu, İrfan, Yürekli, Yakup, Bolaman, Ali Zahit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Galenos Publishing 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6110447/
https://www.ncbi.nlm.nih.gov/pubmed/29806594
http://dx.doi.org/10.4274/tjh.2017.0372
_version_ 1783350473594503168
author Cengiz, Arzu
Arda, Hayri Üstün
Döğer, Firuzan
Yavaşoğlu, İrfan
Yürekli, Yakup
Bolaman, Ali Zahit
author_facet Cengiz, Arzu
Arda, Hayri Üstün
Döğer, Firuzan
Yavaşoğlu, İrfan
Yürekli, Yakup
Bolaman, Ali Zahit
author_sort Cengiz, Arzu
collection PubMed
description OBJECTIVE: The aim of this study was to evaluate the relation between the rate of fluorine-18 (18F) fludeoxyglucose (FDG) uptake and CD38 and CD138 expression in myeloma cells in bone marrow and other clinical parameters in patients with multiple myeloma (MM). MATERIALS AND METHODS: Patients with the diagnosis of MM who underwent 18F-FDG positron emission tomography/computed tomography (PET/CT) for initial staging were evaluated retrospectively. We analyzed a total of 42 patients (43-83 years old, mean: 64.4±9.9). Hematological and biochemical tests including hemoglobin, hematocrit, C-reactive protein, β2-microglobulin, creatinine, albumin, calcium, lactate dehydrogenase, and erythrocyte sedimentation rate were recorded. In bone marrow samples, plasma cell ratio and CD38 and CD138 immunohistochemical staining were evaluated. On PET/CT images, mean standardized uptake values (SUV(mean)) of the right anterior and posterior iliac crest and right proximal femora were calculated. The correlations between the average SUV(mean) of bone marrow and CD38- and CD138-expressing myeloma cells and other parameters were analyzed by Spearman’s correlation test. Values of p<0.05 were considered statistically significant. RESULTS: Types of MM were IgG(K) (45%), IgG(L) (21%), IgA(K) (7%), IgA(L) (10%), and others (17%). Thirty-two (76%) patients were at stage III according to the Salmon-Durie staging system. There was a statistically significant positive correlation between bone marrow FDG uptake and percentage of plasma cells in bone marrow and CD38 and CD138 expression in plasma cells (r=0.403, r=0.339, and r=0.409) and β2-microglobulin and C-reactive protein levels (r=0.676, r=0.541). There was a negative correlation between bone marrow FDG uptake and hemoglobin and hematocrit values (r=-0.377 and r=-0.368). Other hematological parameters were not correlated with FDG uptake in bone marrow. CONCLUSION: Increased FDG uptake is correlated with the percentage of CD38 and CD138 expression in plasma cells in bone marrow. In addition to initial staging, 18F-FDG PET/CT is useful in treatment planning and prognostic evaluation in MM patients.
format Online
Article
Text
id pubmed-6110447
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Galenos Publishing
record_format MEDLINE/PubMed
spelling pubmed-61104472018-09-01 Correlation Between Baseline 18F-FDG PET/CT Findings and CD38- and CD138-Expressing Myeloma Cells in Bone Marrow and Clinical Parameters in Patients with Multiple Myeloma Cengiz, Arzu Arda, Hayri Üstün Döğer, Firuzan Yavaşoğlu, İrfan Yürekli, Yakup Bolaman, Ali Zahit Turk J Haematol Research Article OBJECTIVE: The aim of this study was to evaluate the relation between the rate of fluorine-18 (18F) fludeoxyglucose (FDG) uptake and CD38 and CD138 expression in myeloma cells in bone marrow and other clinical parameters in patients with multiple myeloma (MM). MATERIALS AND METHODS: Patients with the diagnosis of MM who underwent 18F-FDG positron emission tomography/computed tomography (PET/CT) for initial staging were evaluated retrospectively. We analyzed a total of 42 patients (43-83 years old, mean: 64.4±9.9). Hematological and biochemical tests including hemoglobin, hematocrit, C-reactive protein, β2-microglobulin, creatinine, albumin, calcium, lactate dehydrogenase, and erythrocyte sedimentation rate were recorded. In bone marrow samples, plasma cell ratio and CD38 and CD138 immunohistochemical staining were evaluated. On PET/CT images, mean standardized uptake values (SUV(mean)) of the right anterior and posterior iliac crest and right proximal femora were calculated. The correlations between the average SUV(mean) of bone marrow and CD38- and CD138-expressing myeloma cells and other parameters were analyzed by Spearman’s correlation test. Values of p<0.05 were considered statistically significant. RESULTS: Types of MM were IgG(K) (45%), IgG(L) (21%), IgA(K) (7%), IgA(L) (10%), and others (17%). Thirty-two (76%) patients were at stage III according to the Salmon-Durie staging system. There was a statistically significant positive correlation between bone marrow FDG uptake and percentage of plasma cells in bone marrow and CD38 and CD138 expression in plasma cells (r=0.403, r=0.339, and r=0.409) and β2-microglobulin and C-reactive protein levels (r=0.676, r=0.541). There was a negative correlation between bone marrow FDG uptake and hemoglobin and hematocrit values (r=-0.377 and r=-0.368). Other hematological parameters were not correlated with FDG uptake in bone marrow. CONCLUSION: Increased FDG uptake is correlated with the percentage of CD38 and CD138 expression in plasma cells in bone marrow. In addition to initial staging, 18F-FDG PET/CT is useful in treatment planning and prognostic evaluation in MM patients. Galenos Publishing 2018-09 2018-08-05 /pmc/articles/PMC6110447/ /pubmed/29806594 http://dx.doi.org/10.4274/tjh.2017.0372 Text en © Copyright 2018, Turkish Journal of Hematology, Published by Galenos Publishing. http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Cengiz, Arzu
Arda, Hayri Üstün
Döğer, Firuzan
Yavaşoğlu, İrfan
Yürekli, Yakup
Bolaman, Ali Zahit
Correlation Between Baseline 18F-FDG PET/CT Findings and CD38- and CD138-Expressing Myeloma Cells in Bone Marrow and Clinical Parameters in Patients with Multiple Myeloma
title Correlation Between Baseline 18F-FDG PET/CT Findings and CD38- and CD138-Expressing Myeloma Cells in Bone Marrow and Clinical Parameters in Patients with Multiple Myeloma
title_full Correlation Between Baseline 18F-FDG PET/CT Findings and CD38- and CD138-Expressing Myeloma Cells in Bone Marrow and Clinical Parameters in Patients with Multiple Myeloma
title_fullStr Correlation Between Baseline 18F-FDG PET/CT Findings and CD38- and CD138-Expressing Myeloma Cells in Bone Marrow and Clinical Parameters in Patients with Multiple Myeloma
title_full_unstemmed Correlation Between Baseline 18F-FDG PET/CT Findings and CD38- and CD138-Expressing Myeloma Cells in Bone Marrow and Clinical Parameters in Patients with Multiple Myeloma
title_short Correlation Between Baseline 18F-FDG PET/CT Findings and CD38- and CD138-Expressing Myeloma Cells in Bone Marrow and Clinical Parameters in Patients with Multiple Myeloma
title_sort correlation between baseline 18f-fdg pet/ct findings and cd38- and cd138-expressing myeloma cells in bone marrow and clinical parameters in patients with multiple myeloma
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6110447/
https://www.ncbi.nlm.nih.gov/pubmed/29806594
http://dx.doi.org/10.4274/tjh.2017.0372
work_keys_str_mv AT cengizarzu correlationbetweenbaseline18ffdgpetctfindingsandcd38andcd138expressingmyelomacellsinbonemarrowandclinicalparametersinpatientswithmultiplemyeloma
AT ardahayriustun correlationbetweenbaseline18ffdgpetctfindingsandcd38andcd138expressingmyelomacellsinbonemarrowandclinicalparametersinpatientswithmultiplemyeloma
AT dogerfiruzan correlationbetweenbaseline18ffdgpetctfindingsandcd38andcd138expressingmyelomacellsinbonemarrowandclinicalparametersinpatientswithmultiplemyeloma
AT yavasogluirfan correlationbetweenbaseline18ffdgpetctfindingsandcd38andcd138expressingmyelomacellsinbonemarrowandclinicalparametersinpatientswithmultiplemyeloma
AT yurekliyakup correlationbetweenbaseline18ffdgpetctfindingsandcd38andcd138expressingmyelomacellsinbonemarrowandclinicalparametersinpatientswithmultiplemyeloma
AT bolamanalizahit correlationbetweenbaseline18ffdgpetctfindingsandcd38andcd138expressingmyelomacellsinbonemarrowandclinicalparametersinpatientswithmultiplemyeloma